Hematology Specialists
Association
Meetings and
Congresses
[email protected]
www.hematology.org.tr
Hematology Specialists Association
Executive Committee
President
Prof. Suleyman Dincer, MD
Hisar Intercontinental Hospital, Istanbul
Secretary
Prof. Birol Guvenc, MD
Cukurova University, Adana
Member
Prof. Serdar Bedii Omay, MD
Mardin Artuklu University, Mardin
Member
Prof. Ayşen Timuragaoglu, MD
Emsey Hospital, Istanbul
Member
Prof. Orhan Ayyildiz, MD
Dicle University, Diyarbakir
Member
Prof. Sehmuz Ertop, MD
Bulent Ecevit University, Zonguldak
Member
Prof. Salih Aksu, MD
Hacettepe University, Ankara
1
Mission and Goals
Mission
Hematology Specialists Association (HSA) is a non-profit organization for both clinicians and scientists devoted to the scientific, medical,
practical, technical, administrative, and educational aspects of Hematology
in Turkey and beyond. By providing educational and training opportunities,
the HSA contributes towards improving the health of patients suffering from
blood diseases.
Goals
Hematology Specialists Association aims;
• to provide educational and training opportunities for the clinicians
and scientist working in the field of hematology,
• to create a collaborative network made up of associations, institutions, clinicians, scientists, and nurses willing to share their experience and knowledge,
• to spread the information about the most recent developments in
hematology,
• to provide educational materials and resources to people and their
relatives affected by hematologic disorders,
• to improve the quality of patient care in hematology in Turkey and
beyond,
• to represent Turkish Hematology at the international level.
2
Content Partners
MDS Foundation
Leukemia&Lymphoma Society
American Cancer Society
International Myeloma Foundation
National Marrow Donor Program
Kyrgyzstan Hematology Institute
Uzbekistan Hematology Institute
Azerbaijan Hematology Institute
3
International Eurasian Hematology
Congress
HSA has been annually organizing the International Eurasian
Hematology Congress, one of the largest medical meetings in Turkey since
2010. The International Eurasian Hematology Congress is a scientific event
providing latest developments on clinical and experimental researches in
hematologic disorders and establishing an international collaborative network of medical professionals.
The 5th International Eurasian Hematology Congress was held with
great success on 15-19 October, 2014, in Antalya, Turkey. This event attracted over 800 delegates, 300 of them from 34 different countries. Sixty five
world known speakers presented their latest research findings and perspectives on the hematologic diseases. All delegates had opportunity to participate in group discussions and share their ideas and experiences. Moreover,
a number of selected abstracts were published in the supplement of Leukemia
Research journal.
4
Invitation to the 6th International
Eurasian Hematology Congress
Dear Colleagues,
I would like to draw your attention to the 6th International Eurasian Hematology
Congress which will take place in Antalya, Turkey on 14-18, October, 2015.
This extraordinary event will provide educational lectures in the field of hematology, focusing on practical treatment and case studies. Major emphasis will be
given to new therapeutics, diagnosis and management of high risk patients.
The speakers are internationally recognized experts in the field of hematology
and will be also available for group discussions and workshops during the meeting. Additionally, debate sessions will highlight topics that are currently controversial.
Turkey is a place where East meets West, so this congress inspires and creates
a wide collaborative network of clinicians and scientists from all over the
world.
The congress will be held in Antalya, the fourth biggest touristic center of the
world, one of the most beautiful cities of Turkey, with its magnificent nature,
entertainment centers, sport and culture activities, awarded beaches, and beautiful sea.
Don’t miss this unique opportunity!
Further details can be found at: www.hematology.org.tr
Yours sincerely,
Prof. Suleyman DINCER , MD
Prof. Giuseppe SAGLIO , MD
Prof. Birol GUVENC , MD
President of HSA
Congress President
Secretary of HSA
5
6
Past Meetings
V. International Eurasian Hematology Congress
15-19 October 2014 Mardan Palace- Kundu / Antalya
IV. International Eurasian Hematology Congress
09-13 October 2013 Mardan Palace- Kundu / Antalya
III. International Eurasian Hematology Congress
17-21 October 2012 Mardan Palace- Kundu / Antalya
II. International Eurasian Hematology Congress
13-16 October 2011 Mardan Palace- Kundu / Antalya
I. International Eurasian Hematology Congress
7-10 October 2010 Maritim Pine Beach Resort- Belek / Antalya
7
8
V. INTERNATIONAL EURASIAN HEMATOLOGY
CONGRESS PROGRAM
15-19 OCTOBER 2014
15 October 2014 Wednesday
16:00-16:30 Opening Speech
Dr. Suleyman Dincer
Specific Lectures
CML: How do We Have to Treat our CML Patients in the
Era of Genetic Imatinib?
How Should We Treat Hodgkin Lymphoma?
Moderators: Dr. Salih Aksu, Dr. Cengiz Beyan, Dr. Oktay Bilgir
Dr. Hagop Kantarjian
17:00-17:30 The Essential Management of AML
Dr. Alan Burnett
17:30-18:00 The Essential Management of Adult ALL
Dr. Dieter Hoelzer
18:00-18:30
Next Generation Micro-Analysis and Diagnosis Using
Computational Imaging, Crowd-sourcing and Gaming
18:30-19:00 Radiation and Leukemias
How Should We Treat MDS?
10:30-10:45 Open Coffee Break and Discussion with the Speakers
Moderators: Dr. Birol Guvenc, Dr. Giuseppe Saglio
16:30-17:00
16 October 2014 Thursday
Moderators: Dr. Serdar Bedii Omay, Dr. Mustafa Solak, Dr. Duzgun Ozatli
Myelodysplastic Syndromes: Old and New Classifications
09:00-09:30
Dr. Peter Greenberg
and Prognostic Scores
Dr. Giullermo Garcia
09:30-10:00 Molecular Alterations of MDS
Manero
10:00-10:30 Standard Treatment of MDS Including Transplant
Dr. Elias Jabbour
Dr. Aydogan Ozcan
Dr. Robert Gale
19:00-20:00 Welcome Cocktail
10:45-11:15 Diagnosis and Staging
First-line Therapy, Evaluation of Response and Second
11:15-11:45
Line Therapy
11:45-12:45 Lunch Break
Dr. Evren Ozdemir
Dr. Alessandro Levis
Specific Lectures
Moderators: Dr. Osman Ilhan, Dr. Vahap Okan
12:45-13:15 ECP for Certain Transplant Rejection
Dr. Claudia Del Fante
13:15-13:45 Iron Metabolism: New Horizon
Dr. Hanan Hamed
13:45-14:15 Graft Engineering to Prevent Viral Infection
Dr. Francesco Saglio
The Future: New Targets for Therapy of Hematological Malignancies - 1
Moderators: Dr. Filiz Vural, Dr. Tulin Tuglular Firatli
14:15-14:45 New Targets in ALL
Dr. Sabina Chiaretti
14:45-15:15 New Targets in AML: Only for Minimal Residual Disease? Dr. Mehmet Yilmaz
Products Situation of the Biosimilar in Turkey and in the
15:15-15:45
Dr. Alper Iskit
World
15:45-16:00 Open Coffee Break and Discussion with the Speakers
The Future: New Targets for Therapy of Hematological Malignancies - 2
Moderators: Dr. Sehmuz Ertop, Dr. Hakan Goker, Dr. Mehmet Turgut
16:00-16:30 New Targets in MPNs
New Indications for Old Antibodies: HUS / PNH: A Model
16:30-17:00
Disease
Infections in Hematology
Dr. Tariq Mughal
Dr. Igor Lisukov
Moderators: Dr. Aysen Timuragaoglu, Dr. Nilgun Sayinalp
17:00-17:30 IFI Management: Putting Theory into Practice
Dr. Samir Agrawal
17:30-18:00 New Antibiotic Strategy in Neutropenia
Prophylactic Anti Fungal Treatment in Hematologic
18:00-18:30
Malignancies
Dr. Omrum Uzun
17 October 2014 Friday
Dr. Esin Senol
18 October 2014 Saturday
How to Manage Chronic Lymphoid Leukemias
Moderators: Dr. Orhan Ayyildiz, Dr. Oral Nevruz, Dr. Ahmet İfran
Stem Cell Transplant - 1
Moderators: Dr. Suleyman Dincer, Dr. Deniz Sargin, Dr. Yener Koc
09:00-09:30 Current and Evolving Therapy of CLL
Dr. Susan O’ Brien
09:30-10:00 Chimeric Antigen Receptor T Cells for Treatment of CLL
Dr. J. Joseph Melenhorst
09:00-09:30 CAR T-Cell Therapy
Dr. Hanan Hamed
09:30-10:00 Transplant in Thalassemia: an Update
Dr. Federica Pilo
10:00-10:30 What is Essential to Know About Stem Cells
Dr. Albert Donnenberg
10:00-10:15 Open Coffee Break and Discussion with the Speakers
How to Manage Chronic Myeloid Leukemias and MPNs
10:30-10:45 Open Coffee Break and Discussion with the Speakers
Moderators: Dr. Selim Yavuz, Dr. Guray Saydam
Non-Hodgkin Lymphoma
10:15-10:45 CML Response Monitoring in 2014
Dr. Naeem Chaudrhi
10:45-11:15 How I Treat Essential Thrombocythemia
Dr. Jiri Schwarz
Moderators: Dr. Mustafa Cetin, Dr. Mehmet Dagli, Dr. Hakan Akbulut
11:15-11:45 How I Manage PV
Dr. Petro Petrides
10:45-11:15 How I Manage Indolent Non-Hogkin Lymphoma
Dr. Berksoy Sahin
11:15-11:45 How I Manage Mantle Cell Lymphoma
Dr. Carmino De Souza
11:45-12:15 How I Manage DLBCLs Cell Lymphoma
Dr. Khaled Halahleh
11:45-12:45 Lunch Break
How to Treat Multiple Myeloma
Moderators: Dr. Saidjalal Baxramov, Dr. Rauf Haznedar, Dr. Levent Undar
Which is Best and Most Convenient Treatment of
12:45-13:15
Relapsed and Refractory Cases in Multiple Myeloma
Dr. Michel Delforge
13:15-13:45 New Drugs in Multiple Myeloma
Dr. Rafat Abanour
12:15-13:30 Lunch Break
Stem Cell Transplant – 2
Moderators: Dr. Sevgi Kalayoglu Besisik, Dr. Bulent Eser, Dr. Gulyuz Ozturk
13:45-14:15 Optimizing Treatment of Multiple Myeloma Complications Dr. Evangelos Terpos
14:15-14:45
MRD Monitoring in Multiple Myeloma: Where are We
Now?
Dr. Bruno Paiva
14:45-15:00 Open Coffee Break and Discussion with the Speakers
Moderators: Dr. Turker Cetin, Dr. Ali Kosar, Dr. İsmail Sari
15:30-16:00
Diagnosis and Management of Peri-Operative Risk
(Bleeding and Thrombosis)
Discussing IFI Management with the Guideline in FEN
Patients
16:00-16:30 How to Manage Aplastic Anemia Without SCT
16:30-17:00
Rational Drug Use and Pharmaceutical Industry
Dr. Arnon Nagler
14:00-14:30 Advances in Mobilization Failure
Dr. Nabih Azar
14:30-15:00
Specific Lectures
15:00-15:30
13:30-14:00 Haploidentical Stem Cell Transplant
Cord Blood Transplant: A Reliable Alternative for Elderly
Patients?
Dr. Daniela Cilloni
Closing Ceremony
Dr. Burak Uz
Prof. Giuseppe Saglio, Prof. Suleyman Dinçer, Prof. Birol Guvenc
Dr. Livio Pagano
Dr. Ali Unal
S. Tugba Koc
9
Ataturk Bulvarı 169/40 Bakanlıklar - Ankara / Turkey
Phone: +90 312 425 79 52 • Fax: +90 312 425 79 41
www.hematology.org.tr
10
IV. INTERNATIONAL EURASIAN HEMATOLOGY
CONGRESS PROGRAM
09-13 OCTOBER 2013
10 October 2013 Thursday
Complications and Hematologic Infections Sessions
Moderator: Dr. Sema Anak, Dr. Ali Unal, Dr. Gulyuz Ozturk
09:00-09:30 New Antibiotic Strategy in Neutropenia
09 October 2013 Wednesday
16:00-16:30 Opening Speech
The Patient at the Centre of IFI Management: Putting
Theory Into Practice
Profilactic Anti Fungal Treatment in Hematologic
10:00-10:30
Malignancies
09:30-10:00
Dr. Suleyman Dincer
The Opening Session of the Congress
Moderator: Dr. Giuseppe Saglio, Dr. Birol Guvenc
Treatment of Acute Myeloid Leukemia: Are We Making
16:30-17:00
Dr. Alan Burnett
Progress?
New Strategies With Minimal Residual Disease and
17:00-17:30
Dr. Dieter Hoelzer
Targeted Therapy in Adult Acute Lymphoblastic Leukemia
17:30-18:00 Debate: HL Therapy in 2013: Possible Approaches
Dr. Alessandro Levis
18:00-18:30 Iron Overload in MDS
Dr. Eliezer Rachmilewitz
18:30-19:00 Cancer Stem Cells: An Update
Dr. Albert Donnenberg
Dr. Omrum Uzun
Dr. Samir Agrawal
Dr. Esin Senol
10:30-10:45 Coffee Break
MPN
Moderator: Dr. Aysen Timuragaoglu, Dr. Cengiz Beyan
10.45-11:15 Molecular Genetics of MPNs
Dr. Daniela Cilloni
11:15-11:45 Therapeutic Advances in MPN
Dr. Selim Yavuz
11:45-12:15 Transplantation in MPN
Dr. Francesco Frassoni
Evidence based management of Essential
12:15-12:45
Thrombocythemia
Dr. Petro E. Petrides
12:45-13:30 Lunch Break
19:00
Opening Cocktail
ALL
Moderator: Dr. Serdar Bedii Omay, Dr. Mustafa Solak, Dr. Hakan Goker
13:30-14:00 Moleculer Genetics of ALL
Dr. Sabina Chiaretti
Dr. Mohamed Said Yousuf
Ahmed
Transplantation in ALL Acute Lymphoblastic Leukemia in Dr. Mohamed Said Yousuf
14:30-15:00
Adolescents Between Pediatric and Adult Camps
Ahmed
14:00-14:30 Ph+ ALL New Era
15:00-15:15 Coffee Break
MDS
Moderator: Dr. Peter Greenberg, Dr. Ali Kosar, Dr. Sehmuz Ertop
Recent Clinical and Molecular Advances in the
15:15-15:45
Management of MDS Patients
15:45-16:15 New Drugs in MDS Treatment
In Elderly Patients With AML Which Patients Should be
Considered Fit or Unfit for Standart Induction Therapy?
Myelodysplastic Syndromes: Who and When Should be
16:45-17:15
Transplanted in the Disease Process?
CML
Moderator: Dr. Giuseppe Saglio, Dr. Hakan Ozdogu
16:15-16:45
17:15-17:45 CML Successful Targeted Therapy
“The congress’s organization were made by Hematology Specialists Association.”
17:45-18:15
Dr. Berksoy Sahin
In DLBL’s Treatment When Autogous and When Allogenic
Therapy Will Apply?
Dr. Guray Saydam
Iron Overload
Moderator: Dr. Maria Domenica Cappellini, Dr. Salih Aksu
Dr. Maria Domenica
Cappellini
Methods to quantify Iron Overload. How reliable is ferritin
Dr. Antonio Piga
plasmatic concentration?
Stem Cell Transplantation and Gene Therapy in the
10:00-10:30
Dr. Emanuele Angelucci
B-Hemoglobinopathies
09:00-09:30 How I treat my hemoglobinopathy patients?
09:30-10:00
10:30-10:45 Coffee Break
11:15-11:45 APL: A Curable Leukemia Without Chemotherapy
Dr. Alessandro Levis
11:45-12:15
Dr. Evren Ozdemir
12:45-13:30 Lunch Break
STC
Moderator: Dr. Suleyman Dincer, Dr. Saidjalal Bakhramov, Dr. Abdulhalim Raimjanov
13:30-14:00 Advances in Mobilization Failure
Dr. Nabih Azar
14:00-14:30 Autologous BMT
Dr. Alev Erikci
14:30-15:00 Bone Marrow Transplantation: Haploidentical Transplantation
Dr. Mustafa Cetin
15:00-15:15 Coffee Break
Multiple Myeloma
Moderator: Dr. Orhan Ayyildiz, Dr. Deniz Sargin, Dr. Filiz Vural
How to Use New Biology to Guide Therapy in Multiple
15:15-15:45
Myeloma
The Treatment of Posttransplantation in Multiple
15:45-16:15
Myeloma: Minimal Residual Disease Control
Doublets, Triplets, or Quadruplets of Novel Agents in Newly
16:15-16:45
Diagnosed Myeloma?
Dr. Francesco Frassoni
AML
Moderator: Dr. Melek Koksal Erkisi, Dr. Nilgun Sayinalp, Dr. Mustafa Cetiner
Aplastic Anemia: Therapeutic Updates in
10:45-11:15
Dr. Emanuele Angelucci
Immunosuppression and Transplantation
High Grade Lymphomas
Moderator: Dr. Mehmet Turgut, Dr. Bulent Eser, Dr. Ismail Sari
12:15-12:45
Dr. Mehmet Ali Ozcan
12 October 2013 Saturday
11:00-11:15 Coffee Break
11:45-12:15 Therapy of DLCLs
Dr. Florian Nolte
Is Going For Cure in Chronic Myeloid Leukemia Possible
Dr. Giuseppe Saglio
and Justifiable?
11 October 2013 Friday
CLL and Indolent Lymphomas
Moderator: Dr. Emili Montserrat, Dr. Oktay Faradjev, Dr. Duzgun Ozatli
Implications of New Prognostic Markers in Chronic
09:00-09:30
Dr. Emili Montserrat
Lymphocytic Leukemia
Emerging Role of Kinase-Targeted Strategies in Chronic
09:30-10:00
Dr. Paolo Ghia
Lymphocytic Leukemia
In The Hematological Malignancies, Minimal Residual Disease
10:00-10:30
Dr. Nikolai Tupitsyn
Criteria During the First Diagnose
10:30-11:00 Low Grade Lymphoma Treatment Strategy
Dr. Peter Greenberg
Minimal Residual Disease in Acute Myeloid Leukemis:
Coming of Age
Dr. Erdal Kurtoglu
Dr. Mehmet Yilmaz
12:15-13:00 Lunch Break
CML
Moderator: Dr. Suleyman Dincer, Dr. Hakan Ozdogu
Monitoring Disease Response in Chronic-Phase Chronic
13:00-13:30 Myloid Leukemia: The Age of Moleculer Assays? What
Place for FISH Analysis in CML
Special Topics
Moderator: Dr. Yurdanur Kilinc, Dr. Turker Cetin, Dr. Atilla Tanyeli
Dr. Elias Jabbour
13:30-14:00 PNH, Atypical HUS
Dr. Mustafa Nuri Yenerel
14:00-14:30 ITP, New Treatment Strategy
Dr. Fahri Sahin
14:30-14:45 Coffee Break
Poster Awards and Presentations
Moderator: Dr. Birol Guvenc, Dr. Guray Saydam
Dr. Michel Delforge
14:45-15:45 Poster Awards and Presentations
Dr. Sergey
Samanskiy
Special Topics
Moderator: Dr. Ahmet Faik Oner, Dr. Bulent Zulfikar, Dr. Armen Gasparyan
Dr. Rafat Abanour
15:45-16:15 Hemophilia, Outcome and Complication
Dr. Alphan Kupesiz
16:15-16:45 Basic Plasma Fractionation
Dr. Zera Tellier
16:45-17:15 Hemophilia Gene Therapy
Dr. Bulent Antmen
17:15-18.15 Rational Use of Drugs
Dr. Kamil Vural
11
12
SCIENTIFIC PROGRAM
17 October 2012 Wednesday
In memory of ATİLLA YALCIN
-Special Session16:00-16:30 Opening Speech
18 October 2012 Thursday
Iron Overload
Suleyman Dincer
Presidential
Giuseppe Saglio, Birol Guvenc
Lectures
09.00-9.30
16:30-17:00 Current therapeutical options for acute myeloid leukemia Alan Burnett
17:00-17:30 How will change stem cell transplantation in the future?
Moderators: Ilhan Tezcan, Yurdanur Kilinc, Nazli D. Kaya
Richard Champlin
17:30-18:00
The impact of genomics in clinical medicine: Tracing
Vera Donnenberg
tumor mutational evolution through single cell genomics
18.00
Opening Cocktail
Chelation therapy in 2012
Antonio Piga
09.30-10.00 Iron Overload in MDS
Eliezer Rachmilewitz
10.00-10.30 Transplantation in thalassemia patients
Gulyuz Ozturk
10.30-10.45 Coffee Break
Myeloproliferative Disorders
Moderators: Osman Özcebe, Ali Keskin, Hakan Ozdogu
10.45-11.15 The complex biology of myeloproliferative disorders
11.15-11.45
Conventional therapy of MPDs: When SCT maybe
indicated?
11.45-12.15 Molecular targeted therapy of MPDs
Selim Yavuz
Selim Yavuz
Mustafa Cetiner
12.30-13.30 Lunch
Myelodysplastic Syndromes
Moderators: Ali Unal, Bulent Eser
13.30-14.00 Biological and clinical heterogeneity of MDS
Giuseppe Saglio
14.00-14.30 Current classification and risk scoring in MDS
Mehmet Ali Ozcan
14.30-15.00 Hypomethylation and hypomethylating agents in MDS
Aysen Timuragaoglu
15.00-15.15 Coffee Break
Acute Lymphoblastic Leukemia
Moderators: Atilla Tanyeli, Yuri Chervonobab
15.15-15.45 Adult ALL therapy in 2012
Dieter Hoeltzer
15.45-16.15 Pediatric ALL therapy in 2012
Bulent Antmen
Chronic Myeloid Leukemia
Moderators: Cengiz Beyan, Salih Aksu
16.15-16.45 Present approaches to CML therapy in 2012
Naeem Chaudhri
16.45-17.15 Monitoring response of CML patients
Guray Saydam
17.15-17.45
19 October 2012 Friday
20 October 2012 Saturday
Practical Approaches in Apheresis and Transfusion
Current diagnostic stratification of CLL patients
Costas Stamatopoulos
09.30-10.00 Current therapy approaches for CLL
Emili Montserrat
10.00-10.30 Present approaches for indolent lymphomas
Berksoy Sahin
10.30-10.45 Coffee Break
High Grade Lymphomas
Moderators: Ali Kosar, Osman İlhan
Diagnosis and risk stratification of high grade
lymphomas
Chemotherapy-antibodies stem cell transplantation?
11.15-12.30 How can we better combine all these approaches for
high-grade lymphomas?
10.45-11.15
12.30-13.00 Hodgkin Lymphoma
Filiz Vural
Burhan Ferhanoglu
Alessandro Levis
13.00-14.00 Lunch
Multiple Myeloma
Conventional therapy of MM therapy in young and
elderly patients
Ismet Aydogdu
Raphael Fonseca
Optimization of Bortezomib Treatment in Multiple
15.00-15.30
Myeloma
Michel Delforge
15.30-15:45 Coffee Break
Stem Cell Transplantation
Moderators: Oktay Faradjov, Nikolai Tupitsyn, Vahap Okan
Fungal infections in the immune-compromised patients:
Which prevention? Which therapy?
Bacterial and viral infections in the immune16:45-17:15 compromised patients: Which prevention? Which
therapy?
16:15-16:45
09:30-09:45 Bening Hematology in Uzbekistan
Current therapeutic options for low-grade malignant
09:45-10:00
lymphomas
How to setup a modern blood bank? Equipment,
10.00-10:30
personnel and management
10.30-10.45 Coffee Break
Ferda Tekinturhan
Abdulhalim Rahimjanov
Saidcalal Bahramov
Oktay Faradjov
Turker Cetin
Transplantation
Moderators: Suleyman Dincer, Deniz Sargin, Hamid Karimov
10.45-11.15 When RIC should be preferred in SCT?
Haploidentical or cord blood stem cells; which and
11.15-11.45
when?
11.45-12.15 Management of graft-versus host disease in 2012
Richard Champlin
Hakan Goker
Ahmet Ifram
Special Topics
14.30-15.00 When proteasome inhibitors in the therapy of MM?
15:45-16:15 Therapeutic use of non hematopoietic stem cells
Moderators: Ercument Ovali, Nilgün Sayinalp
Country-based experiences in apheresis, transfusion,
09.00-09:15
stem cell collection and processing
09:15-09:30 Transplantation in Kirghizstan
12.30-13.30 Lunch
Moderators:Rauf Haznedar, Orhan Ayyildiz
14.00-14.30
Giuseppe Saglio
Chronic Lymphocytic Leukemia and Indolent Lymphomas
Moderators: Şehmuz Ertop, Hasan Kaya
09.00-9.30
What have we learned from CML that are useful for
other hematologic malignancies?
Albert Donnenberg
Sesin Kocagöz
Gokhan Metan
Moderators: Mustafa Solak, Oktay Faradjov, Bulent Zulfukar
The benefits of prophylaxis from early age till adulthood
13.30-14.00
in persons with hemophilia
Diseases and diagnosis of paroxysmal nocturnal
14.00-14.30
hemoglobinuria
Current approaches for paroxysmal nocturnal
14:30-15:00
hemoglobinuria – medical case treatment
Thrombotic microangiopathy: Current knowledge and
15:00-15:30
outcomes with plasma exchange
15:30-15:45 Coffee Break
Jan Blanty
Ozlem Balcik
Fuat Oduncu
Joseph Kiss
Special Topics
Moderators: Ahmet Ozturk, Mehmet Turgut
Importance of genetic classification in the management
15:45-16:15
of AML
16:15-16:45 Best induction therapy in AML
Mustafa Yenerel
16:45-17:15 Which AML patients should be transplanted?
Sevgi Kalayoglu Besisik
17.15-17.45 Atypical HUS
Sibel Kabukcu
17:45-18:15 Rational use of medicines
Birol Guvenc
Mehmet Yilmaz
13
14
BİLİMSEL PROGRAM
13 Ekim 2011 Perşembe
Oturum Başkanları: Prof. Dr. Mustafa Solak - Prof. Dr. Ayşen Timurağaoğlu
16:00-16:30 Açılış Konuşması
Prof. Dr. Süleyman Dinçer
17:00-17:30 Kanser Kök Hücresi
Prof. Dr. Vera Donnenberg
16:30-17:00 Terapötik Kök Hücre Kaynakları
17:30
Açılış Kokteyli
Prof. Dr. Albert Donnenberg
09:30-10:00 Pediyatrik Kök Hücre Transplantasyonu
Prof. Dr. Gülyüz Öztürk
Allojenik Kök Hücre Naklinde Profilaktif
Prof. Dr. Hakan Özdoğu
Tedaviler
10:30-10:45 Kahve Arası
Salon A: 2. Oturum: Oturum Başkanları: Prof. Dr. Cengiz Beyan - Prof. Dr. Ali Ünal Oleg Rukavitsyn
10.45-11:15 GVHD ve Yeni Tedavi Yaklaşımları
Prof. Dr. Seçkin Çagırgan
11:15-11:45 IDSA 2011 Klavuzu
Doç. Dr. Mustafa Pehlivan
Fungal Enfeksiyonların Tedavisinde Son
11:45-12:15
Prof. Dr. Yeşim Taşova
Gelişmeler
Uydu Sempozyumu: Multipl Miyelomda Tedavi Optimizasyonu
(Janssen-Cilag)
Oturum Başkanı: Prof. Dr. Meral Beksaç
12:15-13:30
Yeni Tanı Multipl Miyelom: Hasta Yönetimi
Prof. Dr. Sevgi Kalayoğlu Beşışık
Relaps Refrakter Multipl Miyelomlu Hastaya
Prof. Dr. Rıdvan Ali
Yaklaşım
10:00-10:30
14 Ekim 2011 Cuma
Açılış Seramonisi
Salon A: 1. Oturum: Oturum Başkanları: Prof. Dr. İbrahim Haznedar - Prof. Dr. Sema Anak Prof. Dr. Birol Güvenç
09:00-09:30 KML’de Güncel Tedavi
Prof. Dr. Giuseppe Saglio
09:30-10:00 KML’de Monitörizasyon
Prof. Dr. Giovanna Rege-Cambrin
Yeni TKI’leri Birinci Basamakta
10:00-10:30
Prof. Dr. Philipp Le Coutre
Kullanılmalı Mı?
10:30-10:45 Kahve Arası
Salon A: 2. Oturum: Oturum Başkanları: Prof. Dr. Rauf Haznedar - Prof. Dr. Hakan Göker Gunta Purkale
KML Dışındaki Myeloproliferatif Hastalıklar ve
Prof. Dr. Berksoy Şahin
Yeni Tedavi Olasılıkları
11:15-11:45 Türkiyede MM’nın Tedavisi ve Güncel Sorunlar Prof. Dr. Meral Beksaç
11:45-12:15 Multipl Miyelom’da Yeni Tedavi Algoritmaları
Prof. Dr. Deniz Sargın
Uydu Sempozyumu: AML ve MDS Hastalarında Yeni Tedavi Yaklaşımları ve
12:15-13:30 Sağkalım (Erkim)
AML
Prof. Dr. Ayşen Timurağaoğlu
MDS
Prof. Dr. Mehmet Ali Özcan
13:30-14:00 Öğle Arası
Salon A: 3. Oturum: Oturum Başkanları: Prof. Dr. Serdar Bedii Omay - Prof. Dr. Sait Celal
Bahramov Celalov - Ismailzade Reiman
14:00-14:30 PNH: Yeni Tanı Seçenekleri
Prof. Dr. Bülent Antmen
14:30-15:00 PNH: Klinik ve Yeni Tedavi Yaklaşımları
Prof. Dr. Birol Güvenç
15:00-15:30 MDS Yönetiminde Yeni Yaklaşımlar
Prof. Dr. Norbert Gattermann
15:30-15:45 Kahve Arası
Salon A: 4. Oturum: Oturum Başkanları: Prof. Dr. Orhan Ayyıldız - Doç. Dr. Evren Özdemir Yuri Chervonobab
15:45-16:15 Relaps/Refraktör AML Hastalarında Tedavi
Doç. Dr. Mustafa Çetiner
HUD Hematoloji Vizyonu
16:15-16:45
HUD Derneğinin Vizyon ve Misyonu
Prof. Dr. Birol Güvenç
HUD ve Bilişim Teknolojileri
Pleksus Bilişim Teknolojileri
16:45-17:15 Endüstrinin Hematoloji Vizyonu*
Alexion, BMS
17:15-19:00 Endüstrinin Hematoloji Vizyonu*
Celgene, Eczacıbaşı-Baxter, Erkim, Jansen-Cilag, Novartis, Roche
*Konuşmalar alfabetik sıralamaya göre düzenlenmiştir.
21:00
GALA GECESİ
10.45-11:15
15 Ekim 2011 Cumartesi
Salon A: 1. Oturum: Oturum Başkanları: Prof. Dr. Atilla Tanyeli - Prof.Dr. Süleyman Dinçer Mamia Zodelava
Hematolojik Kök Hücre Transplantasyonunda
09:00-09:30
Prof. Dr. Ali Uğur Ural
Güncel ve Yeni Tedavi Yaklaşımları
13:30-14:00 Öğle Arası
Salon A: 3. Oturum: Oturum Başkanları: Prof. Dr. Mahmut Bayık - Prof. Dr. Ahmet Öztürk Oktay Farajov
Foliküler Lenfomada Erken ve Geç Evredeki
14:00-14:30
Prof. Dr. Claire Harrison
Hastalarda Optimal Tedavi
KLL Tedavisinin Bugünü ve Gelecek Tedaviler,
14:30-15:00
Transplantasyonun Yeri
15:00-15:30 Ph (+) ALL’de Tedavi Yaklaşımları
15:30-15:45 Kahve Arası
Salon A: 4. Oturum: Oturum Başkanları: Prof. Dr. Osman
Abdukhalım Raımzhanov
Rejeneratif Tıp Uygulamaları Bugün ve
15:45-16:15
Gelecek
16:15-16:45 Aferez Teknolojisi Nereye Gidiyor?
16:45-17:15 Kan Bankacığı Nereye Gidiyor?
17:15Avrasya Hematoloji Ortak Çalışmaları
Oktay Farajov
Saidcelal Bakramoc
Mamia Zodeleva
Slobodan Loncarevic
Svetlena Sultan Gaziyeva
Prof. Dr. Zafer Gülbaş
Doç. Dr. Fahri Şahin
Özcebe - Prof. Dr. Türker Çetin Prof. Dr. Ercüment Ovalı
Uzm. Bio. Ferda Tekinturhan
Hızır Uzuner
Azerbaycan
Özbekistan
Gürcistan
Gürcistan
Kazakistan
Rusya
Letonya, Estonya, Kırgızistan, Suriye, Kırım, Bosna Hersek, Ukrayna, Tacikistan,
Filistin, Afganistan
15
16
SCIENTIFIC PROGRAM
THURSDAY, OCTOBER 7, 2010
Room A
13.00 - 13.30 Opening
Room B
SATURDAY, OCTOBER 9, 2010
Room A
Room B
EDUCATORS EDUCATION
CONFERANCES
BASIC HEMATOLOGY EDUCATION
CONFERENCES
08.30 - 10.00
ANEMIAS
Hemolytic Anemias
Acquired Congenital
13.30 - 14.30
AML Diagnosis and
Treatment
Hematopoiesis
Evaluation of Hemogram
10.00 - 10.20
Coffee Break
Platelet Disease
ALL Diagnosis and Treatment
Evaluation of Peripheral Smear
Basic Laboratory Tests in Hematology
10.20 - 11.20
14.30 - 15.30
A Special Branch: Hematology Nursing
The First Diagnosis of Cancer
15.30 - 15.50
Coffee Break
11.20 - 12.20
Satellite Symposium
15.50 - 16.50
CML Diagnosis and
Treatment
Psychosocial Problems in Patients with
Hematological Oncology Hematology KIT
The Role of Nurses in Preparation and Use of
Chemotherapeutic Agents
12.20 - 13.30
Lunch
16.50 - 17.50
CLL Diagnosis and Treatment
13.30 - 14.30
Coagulabilities
14.30 - 15.30
Satellite Symposium
15.30 - 15.50
Coffee Break
Diagnosis Methods in
Hematology
Flow
Cytogenetics
Visualization
19.00
Opening Cocktail
FRIDAY, OCTOBER 8, 2010
Room A
08.30 - 09.00
09.00 - 09.30
09.30 - 10.00
Lymphoma
HL
NHL
10.00 - 10.20
Coffee Break
Approach to Patients with Anemia
Approach to Patients with Leukopenia/
Leukocytosis
Approach to Patients with Trombocytopenia
Management of LAP
Room B
TRANSFUSION
What is Therapeutic Apheresis?
Blood Products and Indications
Transfusion Complications
10.20 - 11.20
FREQUENT ANEMIAS
MM Diagnosis and Treatment Iron Deficiency Anemia and Treatment
Megaloblastic Anemia and Treatment
11.20 - 12.20
MDS Diagnosis and
Treatment
12.20 - 13.30
Lunch
13.30 - 14.30
Transplantation
14.30 - 15.30
Supportive Therapy
15.30 - 15.50
Coffee Break
15.50 - 17.00
Aplastic Anemia
PNH
17.00 - 18.00
Stem Cell Tratment
APPROACH TO HEMOLYTIC ANEMIA
Immune Hemolytic Anemias
Non-Immune Hemolytic Anemias
APPROACH TO COAGULATION DISORDERS
Approach to and Follow-Up of Patients With
Hemophilia
Approach to and Follow-Up of Patients With
Thrombophilia
APPROACH TO HEMOGLOBINOPATHIES
Approach to Patients With Thalassemia
Approach to Patients With Sickle Cell
15.50 - 17.30
20.00
QUIZ
The Two Complications Discussed in the
Treatment of Cancer,
Extravasation and Hypersensitivity
Oral and Dental Health of Hematology Patients
Patients in the Terminal Period and
Supportive Care
Life Quality of Hematology Patients
Patient and Family Education
Ethical and Legal Issues Related to Cancer
Treatment
Gala Dinner
SUNDAY, OCTOBER 10, 2010
09.00 - 10.30
Oral Presentations
10.30 - 11.30
Meeting with Industry
11.30
Board Meeting
APPROACH TO CANCER PATIENTS
Supportive Treatment of Cancer Patients
DISCUSSION
Ask to Expert
17
Educational Activities
Eurasian Hematology Summit
23 April 2014, Shangri- La Bosphorus / Istanbul
Atypical Hemolytic Uremic Syndrome Meeting
22 March 2014, Masel Hotel / Adana
Paroxysmal Nocturnal Hemoglobinuria (PNH) Meeting
14 March 2014, Hilton Hotel / Diyarbakır
Paroxysmal Nocturnal Hemoglobinuria (PNH) Roundtable Meeting
22 December 2012, Masel Hotel / Adana
Eurasian Stem Cell and Apheresis Symposium
05-08 May 2011, The Marmara Hotel / Antalya
18
19
20
Hematology Specialist Association
Ataturk Bulvari 169/40 Bakanliklar/Ankara/Turkey
Phone: +90 312 4257952 • Fax: +90 312 4257941
E-mail: [email protected] • www.hematoloji.org.tr
EURASIAN HEMATOLOGY FORUM
ISTANBUL PROGRAM
09:15
Dear Collegues,
Opening Speech
Prof. Suleyman Dincer
Moderator: Prof. Giuseppe Saglio
As a Hematology Specialists Association with the aim to provide more
scientific platforms for hematologist, we are honored to present our
new joint project together with MD Anderson Department of Leukemia
MPN
09:30-10:00 What is New in MPN
Prof. Elias Jabbour
Eurasian Hematology Forum.
AML
There will be Presentations and Discussion section on the topics MPN,
10:10-10:40 What is New in AML
Prof. Hagop M. Kantarjian
ALL, AML, MDS, CML, CLL. Discussion section will make our Forum
more efficient and let all the participants to share their points of view.
10:50-11:10 Coffee Break
ALL
We are pleased to announce that Eurasian Hematology Forum will be
held in Shangri-la Bosphorus Hotel, Istanbul, on April, 23, 2014.
11:10-11:40 What is New in ALL
Prof. Susan O’Brien
MDS
11:50-12:20 What is New in MDS
Prof. Guillermo Garcia Manero
12:30-13:30 Lunch Break
Moderator: Prof. Birol Guvenc
CML
13:30-14:00 Frontline Therapy
Prof. Suleyman Dincer
Hematology Specialists
Association President
Prof. Birol Guvenc
Hematology Specialists
Association General Secretary
Prof. Giuseppe Saglio
The President of the Meeting
14:10-14:40
Prof. Hagop M. Kantarjian
Milestones and Resistance
CLL
14:50-15:20 What is New in CLL
Prof. Elias Jabbour
Prof. Susan O’Brien
15:30-15:50 Coffee Break
21
HEMATOLOGY SPECIALISTS ASSOCIATION
Ataturk Bulvarı 169/40 Bakanlıklar - Ankara / Turkey
Phone: +90 312 425 79 52 • Fax: +90 312 425 79 41
www.hematology.org.tr • [email protected]
Download

here